Clinical Trials in Fuyang, Anhui

30 recruiting

Showing 120 of 21 trials

Recruiting
Phase 3

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

Immunoglobulin A Nephropathy (IgAN)
Biogen454 enrolled233 locationsNCT06935357
Recruiting
Phase 3

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

Primary Membranous Nephropathy
Biogen180 enrolled93 locationsNCT06962800
Recruiting
Not Applicable

Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion

Stroke, IschemicCerebrovascular; Disorder, Occlusive
First Affiliated Hospital of Wannan Medical College272 enrolled7 locationsNCT06155032
Recruiting
Phase 3

A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
Taizhou Hanzhong biomedical co. LTD190 enrolled63 locationsNCT05652894
Recruiting
Not Applicable

Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion

Brain DiseasesStrokeCerebrovascular Disorders+5 more
The Second Hospital of Anhui Medical University282 enrolled6 locationsNCT07185022
Recruiting
Phase 3

Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2

Acute Ischemic Stroke
Capital Medical University1,192 enrolled12 locationsNCT07263308
Recruiting
Phase 1Phase 2

A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

Biliary Tract Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.102 enrolled43 locationsNCT06431490
Recruiting
Not Applicable

The Effectiveness of Guided Written Exposure Therapy for Complex PTSD in Adolescents

CPTSD, Compelx Post-traumatic Stress Disorder
Peking University120 enrolled2 locationsNCT07325734
Recruiting
Not Applicable

Efficacy and Safety of Home-based Structured Physical Exercise in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke
Capital Medical University208 enrolled6 locationsNCT07271082
Recruiting
Phase 3

Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.246 enrolled60 locationsNCT07107256
Recruiting
Phase 2

Edaravone Dexborneol Sublingual Tablet for the PSCI in Acute Ischemic Stroke Patients

Post-stroke Cognitive Impairment
Simcere Pharmaceutical Co., Ltd226 enrolled21 locationsNCT06315231
Recruiting

China Liver Cancer Clinical Registry Cohort Database (HEAL)

Liver Cancer
Anhui Provincial Hospital10,000 enrolled38 locationsNCT06777485
Recruiting
Phase 2

A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma

Gastroesophageal Adenocarcinoma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.204 enrolled39 locationsNCT06767800
Recruiting
Not Applicable

Statins for Treatment of Primary Intracerebral Hemorrhage

Cerebrovascular DisordersIntracranial HemorrhagesIntracerebral haemorrhage+1 more
The Second Hospital of Anhui Medical University264 enrolled22 locationsNCT07088250
Recruiting
Phase 2

Efficacy and Safety of SR1375 in Adult Patients With CAP

Community-acquired Pneumonia
Shanghai SIMR Biotechnology Co., Ltd.240 enrolled29 locationsNCT06577558
Recruiting
Phase 4

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

HypertensionMTHFR 677 CC or CT GenotypeElevated Plasma Homocysteine (Hcy≥10µmol/L)+1 more
Shenzhen Ausa Pharmed Co.,Ltd32,000 enrolled20 locationsNCT04974138
Recruiting
Phase 4

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

HypertensionMTHFR 677 TT Genotype
Shenzhen Ausa Pharmed Co.,Ltd24,000 enrolled20 locationsNCT04974151
Recruiting
Phase 2

Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma
Anhui Provincial Hospital60 enrolled2 locationsNCT06664021
Recruiting
Phase 2

Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery

Thrombocytopenia
Anhui Provincial Hospital60 enrolled2 locationsNCT06673498
Recruiting
Phase 2

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

Hepatocellular Carcinoma
Anhui Provincial Hospital45 enrolled2 locationsNCT06498622